Osiris Therapeutics, Inc. today announced that it will report its financial results for third quarter ended September 30, 2014, on Friday, November 7, 2014. Lode Debrabandere, Ph.D., President and Chief Executive Officer, and Philip R. Jacoby, Jr., Chief Financial Officer, will provide a company update and discuss results via a webcast and conference call on Friday, November 7, 2014, at 9:00 a.m. ET.
http://ift.tt/1p5Se1Q
http://ift.tt/1p5Se1Q
No comments:
Post a Comment